Form 8-K - Current report:
SEC Accession No. 0001437749-25-002723
Filing Date
2025-02-04
Accepted
2025-02-04 16:18:17
Documents
18
Period of Report
2025-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20250204_8k.htm   iXBRL 8-K 41747
2 EXHIBIT 2.1 ex_774480.htm EX-2.1 18652
3 EXHIBIT 10.1 ex_774481.htm EX-10.1 72428
4 EXHIBIT 10.2 ex_774482.htm EX-10.2 86173
5 EXHIBIT 10.3 ex_774483.htm EX-10.3 16869
  Complete submission text file 0001437749-25-002723.txt   433409

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20250204.xsd EX-101.SCH 3890
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20250204_def.xml EX-101.DEF 13442
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20250204_lab.xml EX-101.LAB 17669
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20250204_pre.xml EX-101.PRE 13419
20 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20250204_8k_htm.xml XML 4792
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

EIN.: 593029743 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 25588477
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)